|
KDM5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.783160E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.276600E-01 |
| Normal-vs-Stage2 |
1.707610E-01 |
| Normal-vs-Stage3 |
1.871570E-02 |
| Normal-vs-Stage4 |
7.577100E-03 |
| Stage1-vs-Stage2 |
1.740250E-01 |
| Stage1-vs-Stage3 |
3.679400E-03 |
| Stage1-vs-Stage4 |
2.797600E-03 |
| Stage2-vs-Stage3 |
4.965800E-01 |
| Stage2-vs-Stage4 |
2.450800E-01 |
| Stage3-vs-Stage4 |
4.973400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.784550E-01 |
| Normal-vs-AfricanAmerican |
3.042600E-01 |
| Normal-vs-Asian |
7.451000E-01 |
| Caucasian-vs-AfricanAmerican |
8.385200E-01 |
| Caucasian-vs-Asian |
4.334800E-01 |
| AfricanAmerican-vs-Asian |
4.824400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.517900E-02 |
| Normal-vs-Female |
6.658600E-01 |
| Male-vs-Female |
6.121900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.601000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.415200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.591800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.637600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.963400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.797610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.902400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.363000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.012170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.825200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.023430E-01 |
| Normal-vs-Grade 2 |
8.761600E-01 |
| Normal-vs-Grade 3 |
2.540000E-02 |
| Normal-vs-Grade 4 |
1.171810E-02 |
| Grade 1-vs-Grade 2 |
1.074770E-01 |
| Grade 1-vs-Grade 3 |
6.098000E-03 |
| Grade 1-vs-Grade 4 |
2.862900E-03 |
| Grade 2-vs-Grade 3 |
4.976000E-03 |
| Grade 2-vs-Grade 4 |
6.480000E-03 |
| Grade 3-vs-Grade 4 |
4.515000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.399200E-01 |
| Normal-vs-ccB subtype |
3.981000E-01 |
| ccA subtype-vs-ccB subtype |
3.883200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.887180E-01 |
| Normal-vs-N1 |
8.142000E-01 |
| N0-vs-N1 |
7.295600E-01 |
|
|
